Literature DB >> 24464709

The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population.

Murray Baron1, Marie Hudson1, Solène Tatibouet2, Russell Steele1, Ernest Lo2, Sabrina Gravel2, Geneviève Gyger1, Tarek El Sayegh2, Janet Pope2, Audrey Fontaine2, Ariel Masseto2, Debora Matthews2, Evelyn Sutton2, Norman Thie2, Niall Jones2, Maria Copete2, Dean Kolbinson2, Janet Markland2, Getulio Nogueira-Filho2, David Robinson2, Mervyn Gornitsky1.   

Abstract

OBJECTIVE: The aim of this study was to compare oral abnormalities and oral health-related quality of life (HRQoL) of patients with SSc with the general population.
METHODS: SSc patients and healthy controls were enrolled in a multisite cross-sectional study. A standardized oral examination was performed. Oral HRQoL was measured with the Oral Health Impact Profile (OHIP). Multivariate regression analyses were performed to identify associations between SSc, oral abnormalities and oral HRQoL.
RESULTS: We assessed 163 SSc patients and 231 controls. SSc patients had more decayed teeth (SSc 0.88, controls 0.59, P = 0.0465) and periodontal disease [number of teeth with pocket depth (PD) >3 mm or clinical attachment level (CAL) ≥5.5 mm; SSc 5.23, controls 2.94, P < 0.0001]. SSc patients produced less saliva (SSc 147.52 mg/min, controls 163.19 mg/min, P = 0.0259) and their interincisal distance was smaller (SSc 37.68 mm, controls 44.30 mm, P < 0.0001). SSc patients had significantly reduced oral HRQoL compared with controls (mean OHIP score: SSc 41.58, controls 26.67, P < 0.0001). Multivariate regression analyses confirmed that SSc was a significant independent predictor of missing teeth, periodontal disease, interincisal distance, saliva production and OHIP scores.
CONCLUSION: Subjects with SSc have impaired oral health and oral HRQoL compared with the general population. These data can be used to develop targeted interventions to improve oral health and HRQoL in SSc.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Sjögren’s syndrome; dental caries; oral health; periodontal disease; quality of life; systemic sclerosis; tooth loss

Mesh:

Year:  2014        PMID: 24464709      PMCID: PMC4103515          DOI: 10.1093/rheumatology/ket441

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  47 in total

1.  Oral health-related quality of life in Germany.

Authors:  Mike T John; Linda LeResche; Thomas D Koepsell; Philippe Hujoel; Diana L Miglioretti; Wolfgang Micheelis
Journal:  Eur J Oral Sci       Date:  2003-12       Impact factor: 2.612

2.  Accuracy and reproducibility of two manual periodontal probes. An in vitro study.

Authors:  Eralp Buduneli; Okay Aksoy; Timur Köse; Gül Atilla
Journal:  J Clin Periodontol       Date:  2004-10       Impact factor: 8.728

3.  Test--retest reliability of Oral Health Impact Profile (OHIP-49) in adults with systemic sclerosis.

Authors:  Hon K Yuen; Sybil L Nelson
Journal:  Spec Care Dentist       Date:  2013-06-19

4.  Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study.

Authors:  A P Andonopoulos; A A Drosos; F N Skopouli; H M Moutsopoulos
Journal:  Clin Exp Rheumatol       Date:  1989 Mar-Apr       Impact factor: 4.473

5.  An assessment of sensitivity to change of the Oral Health Impact Profile in a clinical trial.

Authors:  P F Allen; A S McMillan; D Locker
Journal:  Community Dent Oral Epidemiol       Date:  2001-06       Impact factor: 3.383

6.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

7.  Analysis of the oral manifestations of systemic sclerosis.

Authors:  G Nagy; J Kovács; M Zeher; L Czirják
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1994-02

8.  A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test.

Authors:  P F Kohler; M E Winter
Journal:  Arthritis Rheum       Date:  1985-10

9.  Oral health and the quality of life among older adults: the oral health impact profile.

Authors:  D Locker; G Slade
Journal:  J Can Dent Assoc       Date:  1993-10       Impact factor: 1.316

10.  Analysis of the oral manifestations of systemic sclerosis (scleroderma).

Authors:  R E Wood; P Lee
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1988-02
View more
  22 in total

Review 1.  Orofacial consequences of systemic sclerosis: A systematic review.

Authors:  Rawen Smirani; Nicolas Poursac; Adrien Naveau; Thierry Schaeverbeke; Raphaël Devillard; Marie-Elise Truchetet
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 2.  Clinical significance and usefulness of rehabilitation for systemic sclerosis.

Authors:  Naoki Mugii; Yasuhito Hamaguchi; Susanna Maddali-Bongi
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

3.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

4.  Orofacial manifestations of systemic sclerosis.

Authors:  B J Veale; R Y Jablonski; T M Frech; J D Pauling
Journal:  Br Dent J       Date:  2016-09-23       Impact factor: 1.626

5.  The Canadian systemic sclerosis oral health study II: the relationship between oral and global health-related quality of life in systemic sclerosis.

Authors:  Murray Baron; Marie Hudson; Solène Tatibouet; Russell Steele; Ernest Lo; Sabrina Gravel; Geneviève Gyger; Tarek El Sayegh; Janet Pope; Audrey Fontaine; Ariel Masetto; Debora Matthews; Evelyn Sutton; Norman Thie; Niall Jones; Maria Copete; Dean Kolbinson; Janet Markland; Getulio Nogueira-Filho; David Robinson; Mervyn Gornitsky
Journal:  Rheumatology (Oxford)       Date:  2014-10-06       Impact factor: 7.580

6.  Risk association between scleroderma disease characteristics, periodontitis, and tooth loss.

Authors:  Gaetano Isola; Ray C Williams; Alberto Lo Gullo; Luca Ramaglia; Marco Matarese; Vincenzo Iorio-Siciliano; Claudio Cosio; Giovanni Matarese
Journal:  Clin Rheumatol       Date:  2017-10-07       Impact factor: 2.980

7.  Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III.

Authors:  Murray Baron; Marie Hudson; Solène Tatibouet; Russell Steele; Ernest Lo; Sabrina Gravel; Geneviève Gyger; Tarek El Sayegh; Janet Pope; Audrey Fontaine; Ariel Masetto; Debora Matthews; Evelyn Sutton; Norman Thie; Niall Jones; Maria Copete; Dean Kolbinson; Janet Markland; Getulio Nogueira; David Robinson; Marvin Fritzler; Mervyn Gornitsky
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

8.  The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general population.

Authors:  Marie Dagenais; David MacDonald; Murray Baron; Marie Hudson; Solène Tatibouet; Russell Steele; Sabrina Gravel; Shrisha Mohit; Tarek El Sayegh; Janet Pope; Audrey Fontaine; Ariel Masseto; Debora Matthews; Evelyn Sutton; Norman Thie; Niall Jones; Maria Copete; Dean Kolbinson; Janet Markland; Getulio Nogueira-Filho; David Robinson; Mervyn Gornitsky
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-03-25

9.  Oral manifestations of patients with systemic sclerosis: a meta-analysis for case-controlled studies.

Authors:  Suhan Zhang; Junfei Zhu; Yanshan Zhu; Xiaochao Zhang; Ruifang Wu; Siying Li; Yuwen Su
Journal:  BMC Oral Health       Date:  2021-05-10       Impact factor: 2.757

Review 10.  Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review.

Authors:  Korbinian Benz; Christine Baulig; Stephanie Knippschild; Frank Peter Strietzel; Nicolas Hunzelmann; Jochen Jackowski
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.